All stock lists
Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
Healthcare · Biotechnology
28.18-0.03 (-0.12%)
Insider Score
––Not scored
ZYME Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ZYME Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 4.59 M | 2.41 M | 2.52 M | 27.61 M | 48.73 M |
| Revenue Growth (YoY) | -90.58 % | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | 19.30 M | 15.10 M | 15.40 M | 14.10 M | 14.90 M |
| R&D Expense | 27.43 M | 34.46 M | 31.23 M | 35.58 M | 34.45 M |
| Operating Expenses | 46.73 M | 49.56 M | 46.63 M | 49.68 M | 49.35 M |
| Operating Income | -42.15 M | -47.15 M | -44.12 M | -22.06 M | -623.00 K |
| Pretax Income | -45.29 M | -46.35 M | -41.48 M | -18.27 M | 2.13 M |
| Tax Provision | -273.00 K | -2.19 M | -270.00 K | 1.34 M | -186.00 K |
| Net Income | -45.02 M | -44.16 M | -41.21 M | -19.60 M | 2.32 M |
| EPS (Basic) | -0.62 | -0.59 | -0.55 | -0.26 | 0.03 |
| EPS (Diluted) | -0.62 | -0.59 | -0.55 | -0.26 | 0.03 |
| Shares Outstanding | 72.99 M | 74.67 M | 75.34 M | 75.77 M | 75.34 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.